Qian Dou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qian Dou has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Dongmei Zhao
Department of Human Anatomy, School of Basic MedicalScience, Binzhou Medical University, Yantai, China
1 shared publication Han Zhang
Department of Nephrology
1 shared publication- Hang Tong
Department of Urology The First Affiliated Hospital of Chongqing Medical University Chongqing China
1 shared publication - Hua Gan
Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
1 shared publication - Li Tan
Reproduction Centre, The Second Affiliated Hospital of Zhengzhou University Zhengzhou City Henan Province China
1 shared publication - Liying Ma
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/ STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
1 shared publication
Latest Publications
- 1 January 2022
- Vol. 53 (1) , 133-136
[Influencing Factors of Pregnancy Outcome of in vitro Fertilization-Embryo Transfer].
To analyze the effect of factors relevant to blastocyst transfer on the pregnancy outcome of in vitro fertilization-embryo transfer (IVF-ET). The clinical data of 790 pregnant women who underwent IVF-ET in our hospital from July 2015 to July 2020 were retrospectively analyzed. The pregnancy outcome of blastocysts transferred on day 5 (D5, n=705) and those transferred on day 6 (D6, n=85) were compared. According to the pregnancy outcome, the cases were divided into a live birth group ( n=322) and a non-live birth group ( n=468), and multivariate logistic regression was conducted to study the effect of factors relevant to blastocyst transfer on the live birth outcome of IVF-ET. In the D5 group, the biochemical pregnancy rate, clinical pregnancy rate and live birth rate of blastocyst transfer were 69.93%, 64.96%, and 41.84%, respectively, which were significantly higher than those of the D6 group at 50.59%, 45.88%, and 30.59%, respectively. The difference was statistically significant ( P0.05). Multivariate logistic analysis revealed that age>35 years, years of infertility>5 years, endometrium thicknessP<0.05). The adverse pregnancy outcomes of IVF-ET were found to be associated with age, duration of infertility, endometrial thickness on the day of to blastocyst transfer, trophoblast cell rating, and blastocyst transfer performed after how many days of embryo development, and multiparity, which should be closely monitored, and effective measures should be adopted accordingly to prevent adverse outcomes of pregnancy.
- 1 January 2022
- Vol. 53 (1) , 133-136
[Influencing Factors of Pregnancy Outcome of in vitro Fertilization-Embryo Transfer].
To analyze the effect of factors relevant to blastocyst transfer on the pregnancy outcome of in vitro fertilization-embryo transfer (IVF-ET). The clinical data of 790 pregnant women who underwent IVF-ET in our hospital from July 2015 to July 2020 were retrospectively analyzed. The pregnancy outcome of blastocysts transferred on day 5 (D5, n=705) and those transferred on day 6 (D6, n=85) were compared. According to the pregnancy outcome, the cases were divided into a live birth group ( n=322) and a non-live birth group ( n=468), and multivariate logistic regression was conducted to study the effect of factors relevant to blastocyst transfer on the live birth outcome of IVF-ET. In the D5 group, the biochemical pregnancy rate, clinical pregnancy rate and live birth rate of blastocyst transfer were 69.93%, 64.96%, and 41.84%, respectively, which were significantly higher than those of the D6 group at 50.59%, 45.88%, and 30.59%, respectively. The difference was statistically significant ( P0.05). Multivariate logistic analysis revealed that age>35 years, years of infertility>5 years, endometrium thicknessP<0.05). The adverse pregnancy outcomes of IVF-ET were found to be associated with age, duration of infertility, endometrial thickness on the day of to blastocyst transfer, trophoblast cell rating, and blastocyst transfer performed after how many days of embryo development, and multiparity, which should be closely monitored, and effective measures should be adopted accordingly to prevent adverse outcomes of pregnancy.
- Open Access
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1) , 9884297
PICK1 Deficiency Exacerbates Sepsis‐Associated Acute Kidney Injury
We performed in vitro and in vivo experiments to explore the role of protein kinase C‐binding protein 1 (PICK1), an intracellular transporter involved in oxidative stress‐related neuronal diseases, in sepsis‐related acute kidney injury (AKI). Firstly, PCR, western blotting, and immunohistochemistry were used to observe the expression of PICK1 after lipopolysaccharide‐ (LPS‐) induced AKI. Secondly, by inhibiting PICK1 in vivo and silencing PICK1 in vitro, we further explored the effect of PICK1 on AKI. Finally, the relationship between PICK1 and oxidative stress and the related mechanisms were explored. We found that the expression of PICK1 was increased in LPS‐induced AKI models both in vitro and in vivo. PICK1 silencing significantly aggravated LPS‐induced apoptosis, accompanied by ROS production in renal tubular epithelial cells. FSC231, a PICK1‐specific inhibitor, aggravated LPS‐induced kidney injury. Besides, NAC (N‐acetylcysteine), a potent ROS scavenger, significantly inhibited the PICK1‐silencing‐induced apoptosis. In conclusion, PICK1 might protect renal tubular epithelial cells from LPS‐induced apoptosis by reducing excessive ROS, making PICK1 a promising preventive target in LPS‐induced AKI.
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1) , 9884297
Open AccessPICK1 Deficiency Exacerbates Sepsis‐Associated Acute Kidney Injury
We performed in vitro and in vivo experiments to explore the role of protein kinase C‐binding protein 1 (PICK1), an intracellular transporter involved in oxidative stress‐related neuronal diseases, in sepsis‐related acute kidney injury (AKI). Firstly, PCR, western blotting, and immunohistochemistry were used to observe the expression of PICK1 after lipopolysaccharide‐ (LPS‐) induced AKI. Secondly, by inhibiting PICK1 in vivo and silencing PICK1 in vitro, we further explored the effect of PICK1 on AKI. Finally, the relationship between PICK1 and oxidative stress and the related mechanisms were explored. We found that the expression of PICK1 was increased in LPS‐induced AKI models both in vitro and in vivo. PICK1 silencing significantly aggravated LPS‐induced apoptosis, accompanied by ROS production in renal tubular epithelial cells. FSC231, a PICK1‐specific inhibitor, aggravated LPS‐induced kidney injury. Besides, NAC (N‐acetylcysteine), a potent ROS scavenger, significantly inhibited the PICK1‐silencing‐induced apoptosis. In conclusion, PICK1 might protect renal tubular epithelial cells from LPS‐induced apoptosis by reducing excessive ROS, making PICK1 a promising preventive target in LPS‐induced AKI.